期刊文献+

血管生成拟态蛋白在脑膜瘤组织的表达意义 被引量:2

Expression and significance of vasculogenic mimicryproteins in meningiomas
下载PDF
导出
摘要 探讨血管生成拟态(VM)在脑膜瘤组织中的表达及意义。收集56例脑膜瘤患者术后肿瘤病理标本,同期18例颅内减压术后的脑组织标本为对照,行免疫组织化学SP法染色,检测VM相关蛋白血管上皮钙黏附素(VE-cadherin)、上皮细胞激酶(EphA2)在脑膜瘤的脑膜组织中的表达;Western blot进一步检测两组VE-cadherin、EphA2蛋白表达。结果显示,与正常脑膜组织相比较,VE-cadherin、EphA2在脑膜瘤中表达阳性率显著提高(P<0.01);随着脑膜瘤病理分级的上升,其VE-cadherin、EphA2蛋白的表达逐渐上升。VM形成相关蛋白VE-cadherin、EphA2参与了脑膜瘤的发生与进展。 To investigate the expression and significance of vasculogenic mimicry( VM) proteins in meningiomas. 56 cases of meningioma surgical pathology specimens,and in the same period,18 cases after decompression of normal arachnoid tissue as normal control group. VM related proteins of vascular epithelial calcium( VE-cadherin) and epithelial cell kinase( EphA2) expression in meningioma tissues were detected by immunohistochemical SP staining and Western blot. Results showed that compared with normal control groups,the positive rate of VE-cadherin,EphA2 expression in meningioma increased significantly( P〈0. 01). With the increase of pathological grade of meningiomas,the expression of VE-cadherin and EphA2 protein increased gradually. VE-cadherin and EphA2 protein involved in the VM formation,occurrence and progress in meningioma.
出处 《安徽医科大学学报》 CAS 北大核心 2017年第12期1890-1892,1896,共4页 Acta Universitatis Medicinalis Anhui
基金 安徽省科技攻关项目(编号:12010402113)
关键词 血管生成拟态 VE-CADHERIN EPHA2 脑膜瘤 angiogenesis mimicry VE- cadherin EphA2 meningioma
  • 相关文献

参考文献2

二级参考文献14

  • 1Schlenk R F, Dohner K, Krauter J, et al. Mutations and treat- ment outcome in cytogenetic, ally normal acute myeloid leukemia [J]. N EnglJ Med, 2008,358(18) :1909 -18.
  • 2Kronke J, Schlenk R F, Jensen K O,et al. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a stud- y from the German-Austrian acute myeloid leukemia study group [ J ]. J Clin Oncol, 2011,29 ( 19 ) :2709 - 16.
  • 3Tsuzuki S, Taguchi O, Seto M, et al. Promotion and maintenance of leukemia by ERG[J]. Blood,2011,117(14) :3858 -68.
  • 4Kim S Y, Hwang S H, Song E J, et al. Level of HOXA5 hyperm- ethylation in acute myeloid leukemia is associated with short-term outcome[ J ]. Korean J Lab Med,2010,30 (5) :469 - 73.
  • 5Chang H, Salma F, Yi Q L, et al. Prognostic relevance of immu- nophenotyping in 379 patients with acute myeloid leukemia [ J ]. Leuk Res, 2004 ,28(1) :43 -8.
  • 6Grosveld G C. MNI, a novel player in human AML [ J ]. Blood Cells Mol Dis ,2007,39 ( 3 ) :336 - 9.
  • 7Heuser M, Argiropoulos B, Kuchenbauer F, et al. MN1 overex- pression induces acute myeloid leukemia in mice and predicts AT- RA resistance in patients with AML [ J ]. Blood, 2007,110 ( 5 ) : 1639 - 47.
  • 8Heuser M, Wingen L U, Steinemann D, et al. Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia[J]. Haematologica,2005,90(11) :1484 -921.
  • 9Heuser M, Beutel G, Krauter J, et al. High meningioma 1 ( MN1 ) expression as a predictor for poor outcome in acute mye-loid leukemia with normal cytogenetics [ J ]. Blood, 2006, 108 (12) :3898 -905.
  • 10Rockova V, Abbas S, Wouters B J, et al. Risk stratification of in- termediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers [ J ]. Blood,2011, 118(4) :1069 -76.

共引文献4

同被引文献4

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部